



300+ clients supported annually
250+ IND programs
100+ research papers with large pharmaceutical companies and top research institutions
Global AAALAC-accredited facilities with extensive large-animal species availability
Start your project right away without wait in queue
Complete ADME studies as little as 24 hours, PK/PD studies as little as 72 hours, most studies in 5-10 days
In Vitro ADME Studies – metabolic stability, CYP450 inhibition/induction, protein binding, and transporter interactions to identify liabilities early.
In Vivo PK/TK Studies – rodent and non-rodent PK profiling, dose proportionality, and repeat-dose TK to optimize dosing and support IND toxicology programs.
Bioanalytical Services – LC-MS/MS method development and validation, biomarker/metabolite ID, and GLP-compliant quantitative analysis for regulatory submissions.
Speed – immediate study initiation, results in as little as 24 hours for ADME, 72 hours for PK/PD, and most studies completed in 5–10 days
Experience – ~200 DMPK scientists average 10+ years of industry expertise, led by globally recognized experts
Flexibility – the right size to quickly adapt and tailor solutions to evolving project needs. Our consultative approach ensures the right strategy, the right studies, and the right results — the first time
IND-enabling packages tailored to your submission timeline
Early-phase screening to advanced regulatory bioanalysis
Toxicology studies in rodent, dog, and monkey models
Small- and large-molecule DMPK capabilities
Automated workstations for reproducibility, speed, and quality
Pick stronger candidates earlier
Reduce IND submission risks
Move into pre-clinical and clinical studies with more confidence
Leverage PK/PD studies and modeling to fine-tune dosing and safety strategies
In vitro ADME assays: results in as little as 24 hours, typically in 5 days
In vivo PK/TK studies: no waitlists, as fast as 72 hours, typically in 5–10 days, immediate starts with extensive availability of large-animal species at our global AAALAC-accredited facilities
Bioanalysis: GLP-compliant LC-MS/MS with regulatory-ready reports